Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124
Clinical trial NCT05459688 · COMPLETED
Trial details
- NCT number
- NCT05459688
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-06
- Primary completion
- 2023-11-07
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.